HK Stock Market Move | SEER TECH (06106) surged over 7% in early trading as the company was included in the Hang Seng Composite Index, with the prospect of entering the Stock Connect program.
Xian Gong Intelligence (06106) rose over 7% in the morning session. As of the time of publication, it is up 7.72%, priced at HKD 69.8, with a trading volume of HKD 4.1861 million.
SEER TECH (06106) surged over 7% in early trading. As of the time of writing, it is up by 7.72%, priced at HKD 69.8, with a transaction volume of HKD 4.1861 million.
In terms of news, SEER TECH has been included in the Hang Seng Composite Index, with the index changes to take effect after the market closes on September 4 (Friday) and to be implemented starting September 7 (Monday). Accordingly, the Shanghai and Shenzhen stock exchanges will adjust the scope of investable stocks under the Hong Kong Stock Connect. As a rare representative in the Hong Kong stock markets Siasun Robot & Automation brain sector, SEER TECH's inclusion in the index is seen as an important signal of wider recognition for the smart Siasun Robot & Automation industry in the capital market.
Public information shows that SEER TECH is a body intelligence platform company focused on the "Siasun Robot & Automation brain," with underlying capabilities leaning towards software and algorithms. In the first half of 2026, SEER TECH achieved revenue of 264 million yuan, a year-on-year increase of 67.5%; "Siasun Robot & Automation brain" shipments exceeded 8,000 units, up over 80% year-on-year; and new orders surpassed 467 million yuan, increasing over 60% year-on-year.
Related Articles

HUTCHMED (00013): Reached a licensing agreement with GlaxoSmithKline for KRAS-EGFR antibody-drug conjugates for cancer treatment.

GEELY AUTO (00175) issued 40,500 shares due to the exercise of stock options.

Cangzhou Mingzhu Plastic (002108.SZ) has received approval from the Shenzhen Stock Exchange's Listing Review Center for its application for a private placement of shares.
HUTCHMED (00013): Reached a licensing agreement with GlaxoSmithKline for KRAS-EGFR antibody-drug conjugates for cancer treatment.

GEELY AUTO (00175) issued 40,500 shares due to the exercise of stock options.

Cangzhou Mingzhu Plastic (002108.SZ) has received approval from the Shenzhen Stock Exchange's Listing Review Center for its application for a private placement of shares.

RECOMMEND





